BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kamimura K, Yokoo T, Abe H, Terai S. Gene Therapy for Liver Cancers: Current Status from Basic to Clinics. Cancers (Basel) 2019;11:E1865. [PMID: 31769427 DOI: 10.3390/cancers11121865] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Montaño-Samaniego M, Bravo-Estupiñan DM, Méndez-Guerrero O, Alarcón-Hernández E, Ibáñez-Hernández M. Strategies for Targeting Gene Therapy in Cancer Cells With Tumor-Specific Promoters. Front Oncol 2020;10:605380. [PMID: 33381459 DOI: 10.3389/fonc.2020.605380] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
2 Wang D, Chen L, Gao Y, Song C, Ouyang Z, Li C, Mignani S, Majoral JP, Shi X, Shen M. Impact of molecular rigidity on the gene delivery efficiency of core-shell tecto dendrimers. J Mater Chem B 2021;9:6149-54. [PMID: 34328166 DOI: 10.1039/d1tb01328a] [Reference Citation Analysis]
3 Tong T, Guan Y, Gao Y, Xing C, Zhang S, Jiang D, Yang X, Kang Y, Pang J. Smart nanocarriers as therapeutic platforms for bladder cancer. Nano Res 2022;15:2157-76. [DOI: 10.1007/s12274-021-3753-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Hattab D, Gazzali AM, Bakhtiar A. Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment. Pharmaceutics 2021;13:1009. [PMID: 34371702 DOI: 10.3390/pharmaceutics13071009] [Reference Citation Analysis]
5 Asfiya R, Maiti B, Kamra M, Karande AA, Bhattacharya S. Novel α-tocopherol-ferrocene conjugates for the specific delivery of transgenes in liver cancer cells under high serum conditions. Biomater Sci 2021;9:7636-47. [PMID: 34676384 DOI: 10.1039/d1bm00607j] [Reference Citation Analysis]
6 Kim H, Lee JY, Park SJ, Kwag E, Koo O, Shin JH. ZNF746/PARIS promotes the occurrence of hepatocellular carcinoma. Biochem Biophys Res Commun 2021;563:98-104. [PMID: 34062393 DOI: 10.1016/j.bbrc.2021.05.051] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Sharifian M, Baharvand P, Moayyedkazemi A. Liver Cancer: New Insights into Surgical and Nonsurgical Treatments. CCTR 2021;17:197-206. [DOI: 10.2174/1573394717666210219104201] [Reference Citation Analysis]
8 Shibata O, Kamimura K, Ko M, Sakai N, Abe H, Morita S, Mizusawa T, Sato H, Sakamaki A, Terai S. Effect of Lenvatinib on a Hepatocellular Carcinoma with Fibroblast Growth Factor Receptor 4 Expression: A Case Report and Review of the Literature. Intern Med 2021;60:1709-15. [PMID: 33390501 DOI: 10.2169/internalmedicine.6580-20] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Jia S, Guo B, Wang L, Peng L, Zhang L. The Current Status of SSRP1 in Cancer: Tribulation and Road Ahead. J Healthc Eng 2022;2022:3528786. [PMID: 35463672 DOI: 10.1155/2022/3528786] [Reference Citation Analysis]
10 Quiroz-Reyes AG, Islas JF, Delgado-Gonzalez P, Franco-Villarreal H, Garza-Treviño EN. Therapeutic Approaches for Metastases from Colorectal Cancer and Pancreatic Ductal Carcinoma. Pharmaceutics 2021;13:103. [PMID: 33466892 DOI: 10.3390/pharmaceutics13010103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Anwer A, Khan S, Amir F, Bhat SA, Azam SA, Hasan SK, Afroz M, Waseem R, Islam A, Parveen S, Kazim SN. Novel chimeric vectors harboring hepatitis B viral promoter and reporter gene demonstrated liver-specific significance. Future Virology. [DOI: 10.2217/fvl-2021-0259] [Reference Citation Analysis]
12 Lai E, Astara G, Ziranu P, Pretta A, Migliari M, Dubois M, Donisi C, Mariani S, Liscia N, Impera V, Persano M, Tolu S, Balconi F, Pinna G, Spanu D, Pireddu A, Saba G, Camera S, Musio F, Puzzoni M, Pusceddu V, Madeddu C, Casadei Gardini A, Scartozzi M. Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? Crit Rev Oncol Hematol. 2021;157:103167. [PMID: 33271389 DOI: 10.1016/j.critrevonc.2020.103167] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
13 Kruse RL, Huang Y, Kumbhari V. How to Embrace Gene Therapy in Gastroenterology. Gastroenterology 2022;162:1019-23. [PMID: 35122741 DOI: 10.1053/j.gastro.2022.01.026] [Reference Citation Analysis]
14 Roma-Rodrigues C, Rivas-García L, Baptista PV, Fernandes AR. Gene Therapy in Cancer Treatment: Why Go Nano? Pharmaceutics 2020;12:E233. [PMID: 32151052 DOI: 10.3390/pharmaceutics12030233] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 14.5] [Reference Citation Analysis]
15 Kamimura K, Yokoo T, Abe H, Sakai N, Nagoya T, Kobayashi Y, Ohtsuka M, Miura H, Sakamaki A, Kamimura H, Miyamura N, Nishina H, Terai S. Effect of Diphtheria Toxin-Based Gene Therapy for Hepatocellular Carcinoma. Cancers (Basel) 2020;12:E472. [PMID: 32085552 DOI: 10.3390/cancers12020472] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]